Maverick Simulation Solutions Ltd - Unlisted Shares
Fundamentals
- Current Price
- ₹2,050
- Market Cap
- ₹1,007.34 Cr
- ISIN
- INE1BEQ01014
- Face Value
- ₹10
- P/E Ratio
- 21.06
- EPS
- 97.32
- P/B Ratio
- 10.39
- Book Value
- 197.40
- Debt / Equity Ratio
- 0.23
Key Financials
Profit & Loss
| Metric | FY2025 | FY2024 |
|---|
| Revenue from Operations | 136.31 | 14.22 |
| Growth % | 858.41% | - |
| Operating Expenses | 74.69 | 13.0 |
| Growth % | 473.93% | - |
| Operating Profit | 61.62 | 1.21 |
| Operating Profit Margin % | 45.21% | 8.50% |
| Other Income | 2.56 | 0.23 |
| Finance Costs | 2.84 | 0.15 |
| Depreciation | 0.03 | 0.02 |
| Profit Before Tax | 61.31 | 1.26 |
| Tax | 13.49 | 0.32 |
| Tax % | 22.00% | 25.26% |
| Profit After Tax | 47.82 | 0.95 |
| Growth % | 4958.81% | - |
| PAT % | 35.08% | 6.65% |
| Diluted EPS | 97.32 | 3.95 |
Company Financials
| Metric | FY2025 | FY2024 |
|---|
| Equity Capital | 4.76 | 4.76 |
| Reserves | 92.24 | 20.81 |
| Total Equity | 97.00 | 25.56 |
| Borrowings | 11.01 | 0.00 |
| Provision | 0.06 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 |
| Total Non current Liabilities | 11.07 | 0.00 |
| Borrowings | 12.02 | 7.85 |
| Other Current Liabilities | 43.36 | 53.76 |
| Total current Liabilities | 55.37 | 61.61 |
| Equity + Liabilities | 163.45 | 87.17 |
| Fixed Assets (incl. WIP) | 5.54 | 0.47 |
| Other Non Current Assets | 2.02 | 8.36 |
| Total Non current Assets | 7.56 | 8.83 |
| Trade Receivables | 7.24 | 5.13 |
| Cash & Cash Equivalents | 8.41 | 4.64 |
| Other Current Assets | 140.23 | 68.57 |
| Total current Assets | 155.89 | 78.34 |
| Total Assets | 163.45 | 87.17 |
Shareholding Pattern
- Anuj Chahal
- 78.65%%
- Kanika Chahal
- 0.09%%
- Samir Gupta
- 1.25%%
- Others
- 20.01%%
Strengths & Weaknesses
Strengths
- Proprietary & Patented Products: Flagship simulators like LuSi, TestChest, and the Complete Ophthalmology Suite are patented and proprietary. It also has 8 granted patents and 15 more in process, showing that the IP moat is actively deepening.
- Global Swiss Subsidiary: It has 100% ownership of Organis GmbH (Switzerland), makers of the world's only autonomous human lung simulator, giving Maverick a hard-to-replicate international asset that elevates its credibility well beyond the Indian market.
- Marquee Clientele: With installations across multiple AIIMS campuses, IIT Madras, and state government colleges in Maharashtra and Odisha it creates a strong sales model with India's most trusted healthcare institutions.
- Profitable Revenue Growth: Revenue has scaled from ₹23 Cr in FY23 to ₹106 Cr in FY25 with PAT growing in step reflecting not just top-line momentum but also improving unit economics.
Weaknesses
- Revenue Concentration: The customer base, while prestigious, is heavily concentrated in government institutions making revenue vulnerable to budget cycles, tender delays, and policy shifts.
About Maverick Simulation Solutions Ltd
Maverick Simulation Solutions is an Indian company that builds training simulators for doctors, nurses, and medical students. These simulators allow healthcare professionals to practice medical procedures on realistic models before treating real patients, helping them improve their skills safely.
Board of Directors
- Anuj Chahal - Founder and Managing Director
- Kanika Chahal - Co-Founder and Director
- Sunil Tomar - Director